A Drug Trial to Remember

“This trial shows you can both clear plaque and change cognition. I don’t know that we’ve hit a home run yet. It’s important not to over-conclude on the data. But as a proof of concept, I feel like this is very encouraging.” NYT: New Alzheimer’s Drug Slows Memory Loss in Early Trial Results. Alzheimer’s “affects about 44 million people worldwide, including 5.5 million Americans. It is estimated that those numbers will triple by 2050.”